Type Of Media：バイオ工学系専門誌
Publication/Magazine/Media：日経バイオテク
B-MED is developing a “paste-only artificial pancreas” that uses microneedles to release insulin.
Summary:
B-MED is a startup founded by Professor Matsumoto, the leader of CHANGE research project 2, which is developing a micro-needle insulin patch that can administer insulin according to blood glucose levels. Currently, the treatment for severe diabetes involves an automatic administration method that combines continuous glucose monitoring devices with insulin pumps; however, the maintenance of these devices and their size can be burdensome for patients. Additionally, while islet transplantation is also being attempted, there are issues such as donor shortages, the invasiveness of the surgery, and associated costs. Therefore, B-MED is focusing on the development of a "wearable artificial pancreas," specifically the micro-needle insulin patch made from phenylboronic acid-containing acrylamide gel. This patch uses needles approximately 1mm long, which helps avoid pain points and allows for gradual delivery of the insulin contained within. President Matsumoto hopes that this new treatment method will expand the options available for diabetes treatment.
http://bio.nikkeibp.co.jp/atcl/column/16/021500017/062100285/
